Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision v3.5.0 was added. Revision v3.4.3 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a new Revision: v3.4.2 note and removed the previous government-operating-status notice along with the prior Revision: v3.4.1 entry.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a site-wide government funding notice indicating potential delays and that the NIH Clinical Center is open, and updated the revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe page now includes minor UI/label updates and metadata changes: a Show glossary option, capitalization tweaks to QC-related labels, and a new revision tag (v3.4.0), with no changes to core study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.